An SMS Intervention to Improve Adherence to Stimulant Medications in Adults With ADHD

Not Applicable

• Conditions: Attention Deficit/Hyperactivity Disorder

• Registration Number: NCT04189536
• Lead Sponsor: Massachusetts General Hospital

Brief Summary

This study will assess the efficacy of the text messaging (SMS-based) disease management intervention to improve adherence to stimulants in adults with Attention Deficit/Hyperactivity Disorder (ADHD).

Participants in the study will receive customized text messages twice a day, every day, for a duration of 9 months. The text messages will include reminders to adhere to the individualized medication regimen, reminders to call their clinician for a prescription refill followed by reminders to pick up medication from the pharmacy, and educational reminders about ADHD and its treatment.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-09-19
• Study First Submitted: 2019-12-04
• Study First Submitted QC: 2019-12-04
• Study First Posted: 2019-12-06
• Status Verified: 2022-01
• Last Update Submitted: 2022-01-14
• Last Update Posted: 2022-01-18
• Primary Completion: 2022-09
• Study Completion: 2022-09

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 125

Inclusion Criteria

• Male and female adults 18 to 55 years
• A diagnosis of Diagnostic and Statistical Manual Diploma in Social Medicine (DSM-V) Attention Deficit Hyperactivity Disorder based on clinical assessment
• Is starting stimulant medication or has begun treatment with stimulant medication within six months of study enrollment
• Proficient in English
• Has a cellular phone with text messaging capabilities and is interested in and willing to receive text messages

Exclusion Criteria

• Serious chronic medical or psychiatric condition that, in the investigator's opinion, puts the subject at risk for taking a stimulant
• Pregnant or nursing females
• Investigator and his/her immediate family
• Unwilling/unable to comply with study procedures

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Primary Outcome Measures

Name	Time	Method
Adherence to Stimulants	9 months	Adherence will be analyzed using the timeliness of stimulant medication prescription renewals over the 9 month period.

Trial Locations

Locations (1)

Massachusetts General Hospital; 🇺🇸 Boston, Massachusetts, United States